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Background: A relatively new method of electrocautery, the radiofrequency bipolar hemostatic sealer (RBHS), uses
saline-cooled delivery of energy, which seals blood vessels rather than burning them. We assessed the benefits of
RBHS as a blood conservation strategy in adult patients undergoing multilevel spinal fusion surgery.
Methods: In a retrospective cohort study, we compared blood utilization in 36 patients undergoing multilevel spinal
fusion surgery with RBHS (Aquamantys®, Medtronic, Minneapolis, MN, USA) to that of a historical control group (n = 38)
matched for variables related to blood loss. Transfusion-related costs were calculated by two methods.
Results: Patient characteristics in the two groups were similar. Intraoperatively, blood loss was 55% less in the RBHS
group than in the control group (810 ± 530 vs. 1,800 ± 1,600 mL; p = 0.002), and over the entire hospital stay, red
cell utilization was 51% less (2.4 ± 3.4 vs. 4.9 ± 4.5 units/patient; p = 0.01) and plasma use was 56% less (1.1 ± 2.4 vs.
2.5 ± 3.4 units/patient; p = 0.03) in the RBHS group. Platelet use was 0.1 ± 0.5 and 0.3 ± 0.6 units/patient in the RBHS
and control groups, respectively (p = 0.07). The perioperative decrease in hemoglobin was less in the RBHS group
than in the control group (−2.0 ± 2.2 vs. –3.2 ± 2.1 g/dL; p = 0.04), and hemoglobin at discharge was higher in the
RBHS group (10.5 ± 1.4 vs. 9.7 ± 0.9 g/dL; p = 0.01). The estimated transfusion-related cost savings were $745/case by
acquisition cost and approximately 3- to 5-fold this amount by activity-based cost.
Conclusions: The use of RBHS in patients undergoing multilevel spine fusion surgery can conserve blood, promote
higher hemoglobin levels, and reduce transfusion-related costs.
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Given the recognized risks [1-3] and expense [4,5] of
allogeneic blood transfusion in surgical patients, a
successful blood management program should include
efforts to reduce intraoperative blood loss as a primary
measure of blood conservation. Patients undergoing
posterior spinal fusion surgery can lose substantial amounts* Correspondence: sfrank3@jhmi.edu
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unless otherwise stated.of blood, which can prolong operative time and obscure
visualization of important neural structures. Such patients
often require transfusion of allogeneic blood components
[6]. Methods to reduce transfusion requirements during
spine surgery include controlled hypotension [7], autolo-
gous blood salvage [8,9], and antifibrinolytic medications
[10]. Another method that has been described recently is a
relatively new electrocautery device, which can be described
as a saline-irrigated radiofrequency bipolar hemostatic
sealer (RBHS). Unlike conventional electrocautery, which
burns small blood vessels at temperatures as high as 400°C,
RBHS seals blood vessels by delivering water-cooled
energy that causes vascular contraction at a tissue
temperature <100°C [11,12].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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RBHS is used during liver resection [13], total hip arthro-
plasty [14], and total knee arthroplasty [15]. To our know-
ledge, only one study has evaluated the utility of RBHS in
complex spine surgery. In that study, Mankin et al. [16]
reported significant reductions in blood loss (57%) and
transfusion rates (from 6.6% to 0%) in adolescent patients
undergoing surgery for scoliosis; however, they gave only
the percentage of patients transfused without reporting
the amount of blood transfused or any hemoglobin data.
In the current study, we compared blood loss and transfu-
sion requirements in adults undergoing multilevel spinal
fusion surgery with RBHS to those of a similar patient
cohort in which only conventional unipolar cautery was
used. Our blood management program maintains two
large databases that accurately monitor both intraopera-
tive and perioperative (entire hospital stay) transfusion of
all blood components, including red blood cells (RBCs),
fresh frozen plasma (FFP), and platelets (PLTs). Using
these databases, we assessed blood loss, transfusion re-
quirements, and estimated transfusion-related costs to
assess the utility of RBHS in adult patients undergoing
multilevel spinal fusion surgery.
Methods
After receiving approval from the Johns Hopkins Hospital
institutional review board, we performed a retrospective
cohort study, whereby 36 consecutive patients undergoing
multilevel spinal fusion surgery with the RBHS device
(Aquamantys®, Medtronic, Minneapolis, MN, USA) were
compared to a historical control group (n = 38) that was
propensity-matched for important variables related to
blood loss. These variables included the number of spinal
levels fused, type of surgical procedure (lumbar, thoracic,
or thoracolumbar), the nine specific surgeons performing
the procedures, and the percentage of patients undergoing
revision spinal surgery. Patients in the matched control
group were selected from the operating room medical in-
formation system (ORMIS) database and underwent sur-
gery between August 2012 and January 2013. Patients in
the RBHS group were selected as consecutive surgical
cases during July and August of 2013, when the RBHS
was introduced. Exclusion criteria were preoperative coag-
ulopathy, thrombocytopenia, and refusal of blood product
transfusion.
The RBHS device was set to a power setting of 140,
and the saline flow rate was set to medium. Traditional
unipolar cautery (ConMed System 5000™, Utica, NY, USA)
and intraoperative autologous blood salvage (Brat-2, Sorin
Group, Milan, Italy) were used in both study groups. An
adult-size 225-mL bowl was used for blood salvage,
and salvaged blood was processed and transfused if the
collected volume exceeded 500 mL. Intraoperative
hemoglobin (Hb) triggers were used according to theusual practice at our institution for this type of surgery
(9–10 g/dL intraoperatively and 8–9 g/dL postoperatively).
FFP and PLTs were transfused according to the clinical
judgment of the anesthesiologists and surgeons. Typically,
FFP and PLTs were given if the transfusion requirements
exceeded ½ of the patient's total blood volume (≈5 units
RBCs).
Blood utilization data were obtained from two separate
databases. Intraoperative data were obtained from the elec-
tronic anesthesia records (Metavision®, iMdSoft, Needham,
MA, USA). A detailed description of this database and
its validation have been published previously [6]. Whole
hospitalization blood utilization data and hemoglobin
data (from admission to discharge) were obtained from a
blood management intelligence portal, IMPACT Online®
(Haemonetics, Braintree, MA, USA) [17]. This database
also includes morbidity outcomes based on ICD-9 codes
assigned to each patient upon discharge. We compared the
following morbidity outcomes between the two groups: in-
fection, thrombotic, renal, respiratory, stroke, and myocar-
dial infarction. We also analyzed a composite outcome that
was the presence of any of these morbid events.
We calculated transfusion-related cost by two different
methods. The first method is based on the average cost
to acquire blood components from blood suppliers in
the mid-Atlantic region (acquisition cost). These costs
were calculated as $220/RBC unit, $50/FFP unit, and
$600/PLT unit. The second method is the activity-based
cost of blood, as described by Shander et al. [4], which
accounts for every step in the process of bringing blood
from the donor to the recipient, including all transfusion-
related activities, such as collection, transport, testing, stor-
age, administrative work, and the transfusion process itself.
This cost was determined to be between 3.2 and 4.8 times
the acquisition cost. The average incremental equipment
cost was $493 per surgical case when the RBHS was used.
Sample size and statistical analysis
We performed a sample size calculation based on the
known blood utilization for these types of cases at our
institution [6]. To detect a 25% difference in the number
of blood product units transfused with an α of 0.05 and
power of 0.8, we required an estimated sample size of 32
patients per study group.
Differences in the mean measured values between
groups were analyzed by Student's t tests. Dichotomous
variables were analyzed by the chi-squared test. All tests
were two-tailed. All data are presented as mean ± SD, and
p < 0.05 was used to define significance.
Results
Preoperative and intraoperative patient characteristics
The RBHS and control groups were similar for the variables
of age, sex, body mass, number of spinal levels fused, and
Table 1 Comparison of the radiofrequency bipolar hemostatic sealer and control groups
Variable RBHS group (n = 36) Control group (n = 38) P value
Age (years) 64 ± 14 59 ± 13 0.17
Sex (male/female) 18/18 23/15 0.33
Body mass (kg) 76.6 ± 18.4 74.1 ± 21.2 0.62
Spinal levels fused (median (IQR)) 4 (3, 9) 4 (2, 7) 0.23
Spinal levels fused (mean ± SD) 6.1 ± 4.5 4.9 ± 3.7 0.22
Thoracic fusion 4 (11.1%) 4 (10.5%) 0.67
Lumbar fusion 18 (50%) 20(52.6%) 0.56
Thoracolumbar fusion 14 (38.9%) 14 (36.9%) 0.72
Surgeon specialty (neuro/ortho) 12/24 12/26 0.52
Duration of surgery (h) 6.07 ± 0.42 6.14 ± 0.37 0.89
Revision surgery 8 (22.2%) 7 (18.4%) 0.78
ASA class 2.7 ± 0.1 2.5 ± 0.1 0.19
ASA American Society of Anesthesiologists, IQR interquartile range, RBHS radiofrequency bipolar hemostatic sealer, SD standard deviation, Neuro neurosurgery,
Ortho orthopedic surgery.
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patients undergoing thoracic, lumbar, and thoracolumbar
fusion and the percentage of patients undergoing revision
surgery were also similar in the two groups. Surgeon spe-
cialty (neurosurgery/orthopedic surgery) and duration of
surgery were similar between groups.Blood loss and hemoglobin levels
Intraoperatively, estimated blood loss was 55% less in
the RBHS group than in the control group (p = 0.002).
Likewise, the volume of colloid used was 63% less
(p = 0.04), and the volume of returned salvaged blood was
54% less (p = 0.003) in the RBHS group than that in
the control group (Table 2). The nadir hemoglobin during
hospitalization and the hemoglobin upon discharge
were higher in the RBHS group (Table 2). The decrease
in hemoglobin from admission to discharge was 1.2 g/dL
less in the RBHS group than that in the control group
(p = 0.04), and the hemoglobin concentration at discharge
was 0.8 g/dL higher in the RBHS group (p = 0.01) thanTable 2 Comparison of the radiofrequency bipolar hemostati
Variable RBHS group (n =
Hemoglobin, preoperative (g/dL) 12.5 ± 2.1
Hemoglobin, hospital nadir (g/dL) 9.4 ± 1.6
Hemoglobin upon discharge (g/dL) 10.5 ± 1.4
Δ Hemoglobin (admit - discharge) (g/dL) −2.0 ± 2.2
Crystalloid (mL) 6,000 ± 2,000
Colloid volume (mL) 70 ± 170
Cell salvage (volume returned (mL)) 230 ± 47
Estimated blood loss (mL) 810 ± 530
RBHS radiofrequency bipolar hemostatic sealer.that in the control group. These changes in hemoglobin
levels are summarized in Figure 1.
Transfusion requirements
We also compared the transfusion requirements in the
two groups (Table 3). Intraoperatively, the RBHS group
required 57% fewer units of RBCs (p = 0.009) and 83%
fewer units of FFP (p = 0.002) than did the control
group. The two groups did not differ significantly in
PLT requirements. Over the entire hospital stay, the RBHS
group received 51% fewer units of RBCs (p = 0.01) and
56% fewer units of FFP (p = 0.03) than did the control
group (Figure 2). Although the RBHS group received
fewer platelets than the control group did, the difference
was not statistically significant (p = 0.07).
Outcome data
The incidence of morbid events and the composite
outcome of any morbid event were similar in the two
groups (Table 4). The difference in length of stay wasc sealer and control groups
36) Control group (n = 38) P value
12.9 ± 2.1 0.47
8.5 ± 1.1 0.01
9.7 ± 0.9 0.01
−3.2 ± 2.1 0.04
5,900 ± 2,300 0.88
190 ± 270 0.04
500 ± 200 0.003



























* P= 0.01 vs. Control
Figure 1 Average hemoglobin concentrations compared in the
radiofrequency bipolar hemostatic sealer (RBHS) and control
groups. Baseline hemoglobin was similar between groups, but the
decrease in hemoglobin was less in the RBHS group (P = 0.04), and
the hemoglobin at discharge was higher in the RBHS
group (P = 0.01).
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group and 8.1 ± 6.4 days in the control group; p = 0.35).
Cost savings
When we multiplied the acquisition costs for each unit of
blood component in US dollars by the number of units
saved (difference between groups) during the entire hos-
pital stay, we found that use of the RBHS device saved an
average blood cost of $745/patient (Table 5). Using the
activity-based blood costs [4], the cost savings attributableTable 3 Intraoperative and whole hospitalization transfusion
Variable RBHS group (n = 36)
Transfusion (intraoperative)
RBC (units/patient) 1.2 ± 1.4
FFP (units/patient) 0.3 ± 0.7
PLTs (units/patient) 0 ± 0
RBCs given 19 (53%)
FFP given 7 (19%)
PLTs given 0 (0%)
Transfusion (whole hospital stay)
RBC (units/patient) 2.4 ± 2.4
FFP (units/patient) 1.1 ± 2.4
PLTs (units/patient) 0.1 ± 0.5
RBCs given 21 (58%)
FFP given 7 (19%)
PLTs given 0 (0%)
FFP fresh frozen plasma, PLTs platelets, RBC red blood cells, RBHS radiofrequency bito the RBHS were between $2,384 and $3,576/patient.
After accounting for the RBHS device cost, the net cost
savings were $252/patient (using the blood acquisition
cost), and $1,891–$3,083/patient (using the activity-
based cost). This however, does not include any incremen-
tal costs of evaluating and/or treating transfusion-related
complications.
Discussion
For patients undergoing multilevel spine fusion surgery,
the use of RBHS to achieve hemostasis significantly re-
duced blood loss, transfusion requirements, the de-
crease in Hb, and cost. These findings demonstrate the
effectiveness of RBHS for blood conservation in pa-
tients undergoing these complex surgeries. Average
blood loss was approximately 40% of total blood vol-
ume in the control group but less than 20% of total
blood volume in the treatment group. Although vari-
ous methods of blood conservation have been de-
scribed for orthopedic and spine surgery (controlled
hypotension [7], autologous blood salvage (cell saver)
[8,9], autologous intraoperative normovolemic hemodilu-
tion [18], and antifibrinolytic medications [10]), little pub-
lished evidence has described the beneficial effects of new
methods of electrocautery for achieving hemostasis. It is
noteworthy that in addition to reducing blood loss and
transfusion, the use of RBHS also reduced the variation
in bleeding and transfusion to as little as one-third to
one-half that in the control group, as assessed by standard
deviation of the means for these factors. This finding sug-
gests that RBHS may be useful in reducing blood loss for
spinal fusion patients predisposed to the greatest amount
of bleeding.requirements
Control group (n = 38) P value
2.8 ± 3.4 0.009
1.8 ± 2.8 0.002




4.9 ± 4.5 0.01
2.5 ± 3.4 0.03







































Figure 2 Blood utilization (from admission to discharge)
compared in the radiofrequency bipolar hemostatic sealer
(RBHS) and control groups. Compared to the control group, the
RBHS group used 51% fewer units of red blood cells (P = 0.01) and
56% fewer units of fresh frozen plasma (P = 0.03). The RBHS group
also used fewer platelets (PLTS), but the difference from control did
not reach statistical significance (P = 0.07).
Table 5 Units of blood product saved and costs saved per
surgical case
Blood component Units Acquisition costa Activity-based costb
Savings in RBCs 2.5 $550 $1,760–$2,640
Savings in FFP 1.4 $75 $240–$360
Savings in PLTs 0.2 $120 $384–$576
Blood cost savings $745 $2,384–$3,576
Net cost savingsc $252 $1,891–$3,083
FFP fresh frozen plasma, PLTs platelets, RBCs red blood cells, RBHS
radiofrequency bipolar hemostatic sealer. aCalculated as $220/RBC unit,
$50/FFP unit, and $600/PLT unit, the average cost of blood components in
the mid-Atlantic region. bCalculated as 3.2 to 4.8 times acquisition cost [4].
cCalculated as blood cost savings minus RBHS device costs ($493).
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burning tissue at temperatures up to 400°C [12]. In
contrast, the RBHS method of cautery uses saline-cooled
bipolar delivery of radiofrequency energy, which con-
tracts and seals small blood vessels [19] at tissue
temperature <100°C [14,20,21]. Some evidence also
supports the efficacy of RBHS for hemostasis during
bleeding from bone surfaces, by way of shrinking collagen
in the walls of blood vessels [22]. Because the temperature
is reduced by saline irrigation, RBHS causes less charring
of the tissues and less injury to neural tissues [11],
an important factor during spinal surgery. Advantages ofTable 4 Comparison of clinical outcomes in the









1 (2.8) 5 (13.1) 0.20
Morbid eventsa
Infection 0 (0%) 1 (2.8%) 0.20
Thrombotic 1 (2.8%) 2 (5.3%) 0.87
Renal 1 (2.8%) 2 (5.3%) 0.87
Respiratory 0 (0%) 0 (0%) NS
Stroke 0 (0%) 0 (0%) NS
Myocardial infarction 0 (0%) 0 (0%) NS
NS not significant, RBHS radiofrequency bipolar hemostatic sealer. aMorbid events
were determined by ICD-9 codes at patient discharge from IMPACT Online
(Haemonetics Corp, Braintree, MA, USA).achieving better hemostasis during spine surgery are
not limited to reducing transfusion requirements. Better
visualization of the delicate neural structures may result in
better surgical outcomes; however, assessing this outcome
would require a larger sample size, as neurologic injury is
a relatively uncommon event.
Previous studies in total joint replacement [14,23], liver
resection [13], and scoliosis surgery [16] have reported re-
ductions in bleeding and transfusion by amounts similar
to those determined in our study. In the one study that
showed no difference in blood loss or transfusion require-
ments with the use of RBHS in patients undergoing total
hip arthroplasty, the RBHS device was used alone, without
concomitant use of unipolar cautery, and the overall
transfusion rates were very low (4%–6%) [23]. In our
study, transfusion rates were high, owing to the complex
spine procedures, and both types of cautery were used;
our surgeons agree that for these procedures, both are
needed. These findings suggest that RBHS may not be an
adequate substitute for unipolar cautery during highly
complex surgical procedures.
In addition to confirming the effectiveness of RBHS in
spinal fusion surgery, we showed that patients have a
substantially higher hemoglobin level at discharge when
RBHS is used. Although the difference in morbidity out-
comes and length of stay in our study were not statistically
significant between groups, our study was not powered
with a large enough sample size to adequately compare
these outcomes. However, we did see a trend toward more
favorable overall outcomes in the RBHS group. Consider-
ing the known association between allogeneic blood trans-
fusion and increased morbidity and length of stay [1-3], it
is conceivable that with a larger sample size, improved
outcomes may become apparent when RBHS is used.
The use of RBHS for these complex spinal procedures
led to significant cost savings because of the reduction
in transfusion requirements. The method of calculating
cost savings is clear when blood product acquisition costs
are utilized. The activity-based costs, however, account for
the many steps in the process of bringing blood all the
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method inflates the cost of blood, but each step does in-
deed add incremental cost at some level for management
of the blood supply [4].
Our study had several limitations that should be rec-
ognized. First, the study design was retrospective in that
it used a historical control group. To guard against bias,
however, we chose consecutive patients for whom the
RBHS device was used and propensity matched these
patients to control patients based on clinical predictors
of blood loss and transfusion. The patient characteristics
(Table 1) illustrate that the two groups were comparable.
Second, one particular outcome that we report, intraop-
erative estimated blood loss, is known to be a relatively
inaccurate measure of actual bleeding [24] for a variety
of reasons (irrigation in the suction container, blood on
sponges, and blood on the floor and surgical drapes).
However, because of the retrospective nature of the study,
the clinicians who estimated blood loss were unaware of
and uninvolved with the study and thus less likely to
introduce bias in measuring this parameter. A particular
strength in our study was the use of two comprehensive
databases that have been previously validated [6,17] to ob-
tain both intraoperative and whole-hospital-stay blood
utilization data. Previous studies focused primarily on
intraoperative blood loss and transfusion alone [16,25].
Our databases include whole hospital (from admission to
discharge) nadir and discharge hemoglobin levels and
utilization of both RBC and non-RBC blood components
(FFP and PLTs).
Conclusions
For patients undergoing multilevel lumbar, thoracic, or
thoracolumbar spinal fusion surgery, the use of RBHS to
achieve hemostasis results in reduced blood loss, reduced
intraoperative and whole hospitalization transfusion re-
quirements, higher discharge hemoglobin levels, and sub-
stantial cost savings. These findings suggest that using this
new method as part of a comprehensive patient blood
management program is an efficacious strategy.
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